PDGF-BB Reverses Impaired Neurogenesis Mediated by Tat and Cocaine
PDGF-BB 逆转 Tat 和可卡因介导的受损神经发生
基本信息
- 批准号:8262924
- 负责人:
- 金额:$ 33.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-01-15 至 2016-12-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS neuropathyAddressAdultAffectAlzheimer&aposs DiseaseAnimalsAstrocytesBindingBrainBrain PathologyBrain-Derived Neurotrophic FactorBromodeoxyuridineCREB1 geneCalciumCell Culture TechniquesCell ProliferationCellsCentral Nervous System DiseasesClinicalCocaineCocaine AbuseCoupledDataDementiaDependovirusDown-RegulationDrug abuseEpidemicExhibitsFamilyFibroblast Growth FactorGenerationsGeneticGlial Fibrillary Acidic ProteinGoalsHIVHIV InfectionsHIV SeropositivityHIV-1Hippocampus (Brain)HumanImpaired cognitionImpairmentIn VitroIncidenceIndividualInfectionInterventionLearningLifeLinkMacacaMediatingMemoryMidbrain structureModelingMolecularMonitorMultiple SclerosisMusNeedle SharingNeuraxisNeurodegenerative DisordersNeuronsNeuroprotective AgentsParahippocampal GyrusParkinson DiseasePathogenesisPathologyPathway interactionsPatientsPharmaceutical PreparationsPhospholipase CPlatelet-Derived Growth FactorPlayPrevalenceProtein OverexpressionProteinsProto-Oncogene Proteins c-sisRattusRecombinant adeno-associated virus (rAAV)RegulationReportingRodent ModelRoleSIVSignal PathwaySignal TransductionSmall Interfering RNAStaining methodStainsStem cellsSurvival RateSystemTestingTherapeuticadult neurogenesisantiretroviral therapycocaine exposuredentate gyrusdopaminergic neurondrug of abuseefficacy testingglobal healthhuman embryonic stem cellin vivoindexinginhibitor/antagonistinnovationintravenous drug usemigrationnerve stem cellnervous system disorderneurogenesisneuron apoptosisneuronal survivalneurotrophic factornon-drugnovelplatelet-derived growth factor BBreceptorrelating to nervous systemself-renewalstemsynaptic functiontherapeutic developmenttransmission process
项目摘要
DESCRIPTION (provided by applicant):
HIV-1 infection and drug abuse are interlinked epidemics. Despite the recognized impact of cocaine abuse on the clinical course of HIV-1-associated neurological disorder, the mechanisms underlying the ability of cocaine to modulate central nervous system pathology remain elusive. HIV-infection in the brain can not only impair neuronal (synaptic) function and loss, but can also negatively impact neurogenesis resulting in generation of fewer adult neural progenitor cells (NPCs) in the dentate gyrus of the hippocampus. Cocaine has also been shown to decrease the proliferative capacity of neural progenitors thus impairing the self-renewal ability of the hippocampus. Diminished adult neurogenesis is one of the key factors contributing to pathogenesis of NeuroAIDS. It is therefore essential to first, understand the mechanisms underlying cocaine and HIV-1 protein (Tat)-mediated impairment of NPCs and secondly, to develop therapeutic strategies that overcome the impairment of these key pool of cells. Neurogenesis is regulated by a family of neurotrophins via a wide range of signaling mechanisms. Preliminary data from our group have identified a novel factor, platelet-derived growth factor-B chain (PDGF-B) that acts as a neuroprotective agent for dopaminergic neurons both in vitro and in vivo systems. We have also demonstrated that PDGF-mediated protection of midbrain neurons involves transient receptor potential canonical channels (TRPC)-mediated entry of Ca2+. Ca2+ entry is known to play a critical role both in neuronal survival and in the proliferation of NPCs. We therefore hypothesized that HIV transactivating protein (Tat) & cocaine-mediated impairment of neurogenesis can be reversed by PDGF-B, through the action of TRPC signaling, to restore NPC proliferation and differentiation. To address this hypothesis three specific aims are proposed: 1) Examine PDGF-B-regulated reversal of impaired neurogenesis mediated by HIV Tat & cocaine in hippocampal NPCs with emphasis on TRPC channels, 2) Investigate the signaling pathways involved in PDGF-B-mediated regulation of neurogenesis, and 3) Test the therapeutic potential of Adeno-associated virus 2 (AAV2)-PDGF-B as an intervention strategy for ameliorating Tat & cocaine-mediated inhibition of neurogenesis in murine models of HAND. These studies are both novel and innovative in that the efficacy of PDGF-B in abrogating decreased neurogenesis can be of value not only for HAND but can be applicable to other neurodegenerative diseases as well.
PUBLIC HEALTH RELEVANCE:
Cocaine, a highly potent and addictive brain stimulant, often abused by HIV-infected patients, is known to exacerbate HIV-associated CNS disease while reducing the proliferative and differentiation capacity of the stem cell pool. This proposal is aimed at understanding molecular mechanisms by which a novel target PDGF- B chain, reverses the combined deleterious effects of HIV-1 protein Tat and cocaine on neural progenitor stem cells both in cell culture and in the whole animals.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shilpa J. Buch其他文献
Shilpa J. Buch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shilpa J. Buch', 18)}}的其他基金
Single cell determinants of brain in the context of viral persistence in SIV/cART/cocaine non-human primates
SIV/cART/可卡因非人灵长类动物病毒持续存在时大脑的单细胞决定因素
- 批准号:
10683001 - 财政年份:2023
- 资助金额:
$ 33.41万 - 项目类别:
Title: Pharmacokinetic, pharmacodynamic , and toxicological interactions among Opioids and Cabotegravir
标题:阿片类药物和卡博特韦之间的药代动力学、药效学和毒理学相互作用
- 批准号:
10686187 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
Title: Pharmacokinetic, pharmacodynamic , and toxicological interactions among Opioids and Cabotegravir
标题:阿片类药物和卡博特韦之间的药代动力学、药效学和毒理学相互作用
- 批准号:
10548530 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
在单细胞水平上揭示 HIV/阿片类药物对大脑的影响:SIV/cART/吗啡/恒河猴模型中的转录、染色质可及性和储库分析
- 批准号:
10665734 - 财政年份:2021
- 资助金额:
$ 33.41万 - 项目类别:
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
在单细胞水平上揭示 HIV/阿片类药物对大脑的影响:SIV/cART/吗啡/恒河猴模型中的转录、染色质可及性和储库分析
- 批准号:
10656918 - 财政年份:2021
- 资助金额:
$ 33.41万 - 项目类别:
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
在单细胞水平上揭示 HIV/阿片类药物对大脑的影响:SIV/cART/吗啡/恒河猴模型中的转录、染色质可及性和储库分析
- 批准号:
10220475 - 财政年份:2021
- 资助金额:
$ 33.41万 - 项目类别:
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
在单细胞水平上揭示 HIV/阿片类药物对大脑的影响:SIV/cART/吗啡/恒河猴模型中的转录、染色质可及性和储库分析
- 批准号:
10469423 - 财政年份:2021
- 资助金额:
$ 33.41万 - 项目类别:
Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome
HIV的分子机制
- 批准号:
10161058 - 财政年份:2019
- 资助金额:
$ 33.41万 - 项目类别:
Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome
HIV的分子机制
- 批准号:
10450546 - 财政年份:2019
- 资助金额:
$ 33.41万 - 项目类别:
Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome
HIV的分子机制
- 批准号:
10846423 - 财政年份:2019
- 资助金额:
$ 33.41万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Research Grant














{{item.name}}会员




